Physician profile
Alan Wayne Mcgee
NPI 1255719191
$135,234.95
in general payments reported to CMS, 2019-2025
14 companies · $22K in 2025
The $22K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75K · 2022: $515 · 2023: $8,923 · 2024: $28K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $27K · Consulting Fee: $26K · Food and Beverage: $6,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $27,090.44 |
| Consulting Fee | $26,125.00 |
| Food and Beverage | $6,382.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $75,558.72 | 2021-2025 | Unid_pass |
| Spineart USA INC | $30,315.30 | 2022-2025 | Perla C, Perla Tl, Scarlet Al-T |
| Medyssey USA, INC | $25,625.00 | 2024-2025 | |
| Stryker Corporation | $2,347.99 | 2022-2025 | Mako |
| Curiteva, INC. | $535.11 | 2025 | |
| Ulrich Medical USA, INC. | $442.48 | 2025 | |
| Providence Medical Technology, INC. | $244.79 | 2022-2025 | |
| Carlsmed, INC. | $42.73 | 2024 | Aprevo |
| Baxter Healthcare | $32.21 | 2024 | Floseal |
| Kuros Biosciences USA, INC | $27.46 | 2025 | Magnetos |
| Zimmer Biomet Holdings, INC. | $24.80 | 2025 | Persona |
| Aesculap Implant Systems, LLC | $14.10 | 2023 | Activl |
| Si-Bone, INC. | $13.91 | 2022 | |
| Biocomposites INC | $10.35 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.